{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:40:50Z","timestamp":1788306050782,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012166","name":"Kerkut Charitable trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00467-017-3803-4","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T12:54:26Z","timestamp":1507553666000},"page":"1489-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Thrombotic microangiopathy following haematopoietic stem cell transplant"],"prefix":"10.1007","volume":"33","author":[{"given":"Eleanor G.","family":"Seaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney D.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"3803_CR1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","volume":"30","author":"A Daly","year":"2002","unstructured":"Daly A, Xenocostas A, Lipton J (2002) Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 30:709\u2013715","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, Davies SM, Pluthero FG, Lu L, Laskin BL (2013) Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood 122:2003\u20132007","journal-title":"Blood"},{"key":"3803_CR3","doi-asserted-by":"crossref","unstructured":"De Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay J-O, Neven B, Moussi J, Simon L (2015) Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation 99:1953\u20131959","DOI":"10.1097\/TP.0000000000000601"},{"key":"3803_CR4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","volume":"73","author":"E Holler","year":"1989","unstructured":"Holler E, Kolb H, Hiller E, Mraz W, Lehmacher W, Gleixner B, Seeber C, Jehn U, Gerhartz H, Brehm G (1989) Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 73:2018\u20132024","journal-title":"Blood"},{"key":"3803_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2141.1983.tb02067.x","volume":"54","author":"K Atkinson","year":"1983","unstructured":"Atkinson K, Biggs J, Hayes J, Ralston M, Dodds A, Concannon A, Naidoo D (1983) Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 54:59\u201367","journal-title":"Br J Haematol"},{"key":"3803_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP (2015) A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 29:191\u2013204","journal-title":"Blood Rev"},{"key":"3803_CR7","first-page":"565","volume":"12","author":"J Chapin","year":"2014","unstructured":"Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J (2014) Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clin Adv Hematol Oncol 12:565\u2013573","journal-title":"Clin Adv Hematol Oncol"},{"key":"3803_CR8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","volume":"20","author":"S Jodele","year":"2014","unstructured":"Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, Dixon BP, Teusink A, Pluthero FG, Lu L (2014) Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 20:518\u2013525","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"H-M Tsai","year":"1998","unstructured":"Tsai H-M, Lian EC-Y (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"key":"3803_CR10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"E Batts","year":"2007","unstructured":"Batts E, Lazarus H (2007) Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 40:709\u2013719","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J (2014) Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 124:645\u2013653","journal-title":"Blood"},{"key":"3803_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S (2005) Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:571\u2013575","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR13","first-page":"495","volume":"14","author":"A Pettitt","year":"1994","unstructured":"Pettitt A, Clark R (1994) Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14:495\u2013504","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","volume":"113","author":"R Fuge","year":"2001","unstructured":"Fuge R, Bird JM, Fraser A, Hart D, Hunt L, Cornish JM, Goulden N, Oakhill A, Pamphilon DH, Steward CG (2001) The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 113:58\u201364","journal-title":"Br J Haematol"},{"key":"3803_CR15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy. Blood 118:1452\u20131462","journal-title":"Blood"},{"key":"3803_CR16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","volume":"19","author":"Y Arai","year":"2013","unstructured":"Arai Y, Yamashita K, Mizugishi K, Watanabe T, Sakamoto S, Kitano T, Kondo T, Kawabata H, Kadowaki N, Takaori-Kondo A (2013) Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 19:1683\u20131689","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","volume":"96","author":"BL Laskin","year":"2013","unstructured":"Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, Davies SM, Jodele S (2013) Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 96:217\u2013223","journal-title":"Transplantation"},{"key":"3803_CR18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bmt.2014.40","volume":"49","author":"D Lerner","year":"2014","unstructured":"Lerner D, Dandoy C, Hirsch R, Laskin B, Davies S, Jodele S (2014) Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 49:862\u2013863","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR19","first-page":"339","volume":"3","author":"M Chappell","year":"1988","unstructured":"Chappell M, Keeling D, Prentice H, Sweny P (1988) Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 3:339\u2013347","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1600-6143.2004.00428.x","volume":"4","author":"MC Fortin","year":"2004","unstructured":"Fortin MC, Raymond MA, Madore F, Fug\u00e8re JA, P\u00e2quet M, St-Louis G, H\u00e9bert MJ (2004) Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin\u2013sirolimus combination. Am J Transplant 4:946\u2013952","journal-title":"Am J Transplant"},{"key":"3803_CR21","doi-asserted-by":"crossref","first-page":"e2010033","DOI":"10.4084\/mjhid.2010.033","volume":"2","author":"E Stavrou","year":"2010","unstructured":"Stavrou E, Lazarus HM (2010) Thrombotic microangiopathy in haematopoietic cell transplantation: an update. Mediterr J Hematol Infect Dis 2:e2010033","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"3803_CR22","first-page":"247","volume":"15","author":"Z Zeigler","year":"1995","unstructured":"Zeigler Z, Shadduck R, Nemunaitis J, Andrews D, Rosenfeld C (1995) Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 15:247\u2013253","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","volume":"36","author":"MT Martinez","year":"2005","unstructured":"Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris D, Tichelli A, Gratwohl A, Passweg J (2005) Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 36:993\u20131000","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/bfgp\/elv054","volume":"15","author":"EG Seaby","year":"2015","unstructured":"Seaby EG, Pengelly RJ, Ennis S (2015) Exome sequencing explained: a practical guide to its clinical application. Brief Funct Genomics 15:374\u2013384","journal-title":"Brief Funct Genomics"},{"key":"3803_CR25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","volume":"127","author":"S Jodele","year":"2016","unstructured":"Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, Lane A, Meller J, Medvedovic M, Chen J (2016) The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood 127:989\u2013996","journal-title":"Blood"},{"key":"3803_CR26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2009.07.023","volume":"15","author":"KS Baker","year":"2009","unstructured":"Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C (2009) Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 15:1543\u20131554","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR27","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum L, Babu S, Bedrosian C, Bingham C, Cohen D, Delmas Y, Douglas K (2013) Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"3803_CR28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","volume":"10","author":"A Shimoni","year":"2004","unstructured":"Shimoni A, Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A (2004) Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced. Biol Blood Marrow Transplant 10:484\u2013493","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","volume":"19","author":"A Carmona","year":"2013","unstructured":"Carmona A, D\u00edaz-Ricart M, Palomo M, Molina P, Pino M, Rovira M, Escolar G, Carreras E (2013) Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus\u2013sirolimus on endothelial cells: protective effect of defibrotide. Biol Blood Marrow Transplant 19:1439\u20131445","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1537-2995.2003.00282.x","volume":"43","author":"C Sarkodee-Adoo","year":"2003","unstructured":"Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B (2003) Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion (Paris) 43:78\u201384","journal-title":"Transfusion (Paris)"},{"key":"3803_CR31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR (2009) Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 4:345\u2013353","journal-title":"Clin J Am Soc Nephrol"},{"key":"3803_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","volume":"14","author":"KR Cooke","year":"2008","unstructured":"Cooke KR, Jannin A, Ho V (2008) The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 14:23\u201332","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-6143.2003.00051.x","volume":"3","author":"M Robson","year":"2003","unstructured":"Robson M, C\u00f4te I, Abbs I, Koffman G, Goldsmith D (2003) Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 3:324\u2013327","journal-title":"Am J Transplant"},{"key":"3803_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3324\/haematol.2012.065599","volume":"98","author":"JA Perez-Sim\u00f3n","year":"2013","unstructured":"Perez-Sim\u00f3n JA, Martino R, Parody R, Cabrero M, Lopez-Corral L, Valcarcel D, Martinez C, Solano C, Vazquez L, M\u00e1rquez-Malaver FJ (2013) The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate. Haematologica 98:526\u2013532","journal-title":"Haematologica"},{"key":"3803_CR35","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2014-04-567164","volume":"124","author":"C Cutler","year":"2014","unstructured":"Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW (2014) Tacrolimus\/sirolimus vs tacrolimus\/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood 124:1372\u20131377","journal-title":"Blood"},{"key":"3803_CR36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","volume":"376","author":"SJ Rotz","year":"2017","unstructured":"Rotz SJ, Dandoy CE, Davies SM (2017) ST2 and endothelial injury as a link between GVHD and microangiopathy. N Engl J Med 376:1189\u20131190","journal-title":"N Engl J Med"},{"key":"3803_CR37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.20068","volume":"76","author":"A Belford","year":"2004","unstructured":"Belford A, Myles O, Magill A, Wang J, Myhand RC, Waselenko JK (2004) Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation. Am J Hematol 76:156\u2013162","journal-title":"Am J Hematol"},{"key":"3803_CR38","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","volume":"11","author":"L Murer","year":"2000","unstructured":"Murer L, Zacchello G, Bianchi D, Dall'Amico R, Montini G, Andreetta B, Perini M, DOSSI EC, Zanon G, Zacchello F (2000) Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 11:1132\u20131137","journal-title":"J Am Soc Nephrol"},{"key":"3803_CR39","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1128\/JVI.79.4.2211-2220.2005","volume":"79","author":"A Rahbar","year":"2005","unstructured":"Rahbar A, S\u00f6derberg-Naucl\u00e9r C (2005) Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 79:2211\u20132220","journal-title":"J Virol"},{"key":"3803_CR40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.2830380304","volume":"38","author":"H Takahashi","year":"1991","unstructured":"Takahashi H, Hanano M, Wada K, Tatewaki W, Niwano H, Shibata A, Tsubouchi J, Nakano M, Nakamura T (1991) Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol 38:174\u2013177","journal-title":"Am J Hematol"},{"key":"3803_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0609.1989.tb00284.x","volume":"43","author":"H Cohen","year":"1989","unstructured":"Cohen H, Bull H, Seddon A, Enayat M, Hill F, Woolf N, Machin S (1989) Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 43:207\u2013214","journal-title":"Eur J Haematol"},{"key":"3803_CR42","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V89.4.1224","volume":"89","author":"D Mitra","year":"1997","unstructured":"Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J (1997) Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 89:1224\u20131234","journal-title":"Blood"},{"key":"3803_CR43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1703026","volume":"27","author":"Y Matsuda","year":"2001","unstructured":"Matsuda Y, Hara J, Osugi Y, Tokimasa S, Fujisaki H, Takai K, Ohta H, Kawa-Ha K, Okada S (2001) Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant 27:977\u2013982","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR44","first-page":"w14352","volume":"146","author":"P Hasler","year":"2016","unstructured":"Hasler P, Giaglis S, Hahn S (2016) Neutrophil extracellular traps in health and disease. Swiss Med Wkly 146:w14352","journal-title":"Swiss Med Wkly"},{"key":"3803_CR45","doi-asserted-by":"crossref","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","volume":"7","author":"M Saffarzadeh","year":"2012","unstructured":"Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT (2012) Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 7:e32366","journal-title":"PLoS One"},{"key":"3803_CR46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","volume":"120","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Hovinga JAK, Schatzberg D, Wagner DD, L\u00e4mmle B (2012) Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120:1157\u20131164","journal-title":"Blood"},{"key":"3803_CR47","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.febslet.2010.06.006","volume":"584","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ (2010) Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett 584:3193\u20133197","journal-title":"FEBS Lett"},{"key":"3803_CR48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","volume":"181","author":"H Wang","year":"2015","unstructured":"Wang H, Wang C, Zhao MH, Chen M (2015) Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol 181:518\u2013527","journal-title":"Clin Exp Immunol"},{"key":"3803_CR49","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2013-07-512707","volume":"122","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Cines DB (2013) TMA: beware of complements. Blood 122:1997\u20131999","journal-title":"Blood"},{"key":"3803_CR50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2014.09.028","volume":"21","author":"CE Dandoy","year":"2015","unstructured":"Dandoy CE, Davies SM, Hirsch R, Chima RS, Paff Z, Cash M, Ryan TD, Lane A, El-Bietar J, Myers KC (2015) Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy. Biol Blood Marrow Transplant 21:113\u2013118","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR51","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","volume":"21","author":"J El-Bietar","year":"2015","unstructured":"El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, Davies SM, Jodele S (2015) Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21:1994\u20132001","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.419","volume":"44","author":"Y Inamoto","year":"2009","unstructured":"Inamoto Y, Ito M, Suzuki R, Nishida T, Iida H, Kohno A, Sawa M, Murata M, Nishiwaki S, Oba T (2009) Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. Bone Marrow Transplant 44:43\u201349","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0885066610393634","volume":"27","author":"D Staykov","year":"2011","unstructured":"Staykov D, Schwab S (2011) Posterior reversible encephalopathy syndrome. J Intensive Care Med 27:11\u201324","journal-title":"J Intensive Care Med"},{"key":"3803_CR54","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914\u2013925","journal-title":"Lancet Neurol"},{"key":"3803_CR55","first-page":"152","volume":"2","author":"C Uderzo","year":"2014","unstructured":"Uderzo C, Jodele S, El Missiry M, Ciceri F, Bacigalupo A, Corbacioglu S (2014) Transplant-associated thrombotic microangiopathy (TA-TMA) and consensus based diagnostic and therapeutic recommendations: which TA-TMA patients to treat and when? J Bone Marrow Res 2:152","journal-title":"J Bone Marrow Res"},{"key":"3803_CR56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jca.21352","volume":"30","author":"S Mulay","year":"2015","unstructured":"Mulay S, Kreuter JD, Bryant SC, Elliott MA, Hogan WJ, Winters JL, Gastineau DA (2015) Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. J Clin Apher 30:147\u2013153","journal-title":"J Clin Apher"},{"key":"3803_CR57","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bmt.2009.233","volume":"45","author":"G Kennedy","year":"2010","unstructured":"Kennedy G, Kearey N, Bleakley S, Butler J, Mudie K, Durrant S (2010) Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange. Bone Marrow Transplant 45:699\u2013704","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","volume":"53","author":"S Jodele","year":"2013","unstructured":"Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, Davies SM (2013) Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Transfusion (Paris) 53:661\u2013667","journal-title":"Transfusion (Paris)"},{"key":"3803_CR59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0034-1376153","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C (2014) Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 40:444\u2013464","journal-title":"Semin Thromb Hemost"},{"key":"3803_CR60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705657","volume":"39","author":"M Ostronoff","year":"2007","unstructured":"Ostronoff M, Ostronoff F, Calixto R, Florencio R, Florencio M, Domingues M, Maior AS, Sucupira A, Tagliari C (2007) Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant 39:649\u2013651","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR61","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","volume":"29","author":"P Corti","year":"2002","unstructured":"Corti P (2002) Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplant 29:542\u2013543","journal-title":"Bone Marrow Transplant"},{"key":"3803_CR62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","volume":"22","author":"S Jodele","year":"2016","unstructured":"Jodele S, Fukuda T, Mizuno K, Vinks AA, Laskin BL, Goebel J, Dixon BP, Chima RS, Hirsch R, Teusink A, Lazear D, Lane A, Myers KC, Dandoy CE, Davies SM (2016) Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22:307\u2013315","journal-title":"Biol Blood Marrow Transplant"},{"key":"3803_CR63","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","volume":"22","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A, Wallace G, Teusink-Cross A, Davies SM (2016) Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination. Biol Blood Marrow Transplant 22:1337\u20131340","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3803-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T03:41:01Z","timestamp":1659584461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3803-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3803"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3803-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]}}}